doi:10.1182/blood.V53.5.851.851
2023: Class action lawsuits are initiated, alleging that Novo Nordisk failed to provide adequate warnings about the risk of serious side effects such as gastroparesis, pancreatitis, and gallbladder disease
This will require detailed studies in humans and clinical trials first, said Prof Bryan Williams, the BHFs chief scientific and medical officer
SEE ALSO | Penn researchers use AI to flag underreported side effects discussed by GLP1 drug users "We started with both groups on the Sema, take them off, put them back on, put them back on
In the absence of ovarian dysfunction and insulin resistance in mice, high dietary fat intake increases the risk of endometriosis (69)
The patterns BBB describes mirror the support gaps we hit in our own testing